These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37284018)

  • 61. Association of serum uric acid levels with the progression of Parkinson's disease in Chinese patients.
    Sun CC; Luo FF; Wei L; Lei M; Li GF; Liu ZL; LE WD; Xu PY
    Chin Med J (Engl); 2012 Feb; 125(4):583-7. PubMed ID: 22490478
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effects of soluble TREM2 on motor progression in Parkinson's disease.
    Zhang X; Zhong X; Wang L; Li H; Yang L; Li X; Yu X; Xie A
    Neurosci Lett; 2023 Jun; 807():137277. PubMed ID: 37105353
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Neurodegenerative CSF markers in genetic and sporadic PD: Classification and prediction in a longitudinal study.
    Brockmann K; Schulte C; Deuschle C; Hauser AK; Heger T; Gasser T; Maetzler W; Berg D
    Parkinsonism Relat Disord; 2015 Dec; 21(12):1427-34. PubMed ID: 26475624
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Perivascular space in Parkinson's disease: Association with CSF amyloid/tau and cognitive decline.
    Chen H; Wan H; Zhang M; Wardlaw JM; Feng T; Wang Y
    Parkinsonism Relat Disord; 2022 Feb; 95():70-76. PubMed ID: 35051895
    [TBL] [Abstract][Full Text] [Related]  

  • 65. CSF NFL in a Longitudinally Assessed PD Cohort: Age Effects and Cognitive Trajectories.
    Lerche S; Wurster I; Röben B; Zimmermann M; Machetanz G; Wiethoff S; Dehnert M; Rietschel L; Riebenbauer B; Deuschle C; Stransky E; Lieplt-Scarfone I; Gasser T; Brockmann K
    Mov Disord; 2020 Jul; 35(7):1138-1144. PubMed ID: 32445500
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Decline in renal functioning is associated with longitudinal decline in global cognitive functioning, abstract reasoning and verbal memory.
    Davey A; Elias MF; Robbins MA; Seliger SL; Dore GA
    Nephrol Dial Transplant; 2013 Jul; 28(7):1810-9. PubMed ID: 23166308
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effects of Alzheimer's genetic risk scores and CSF biomarkers in de novo Parkinson's Disease.
    Lee YG; Jeong SH; Park M; Kang SW; Baik K; Jeon S; Lee PH; Sohn YH; Ye BS
    NPJ Parkinsons Dis; 2022 May; 8(1):57. PubMed ID: 35545633
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Parkinson's disease: evolution of cognitive impairment and CSF Aβ
    Lerche S; Wurster I; Röben B; Machetanz G; Zimmermann M; Bernhard F; Stransky E; Deuschle C; Schulte C; Hansson O; Zetterberg H; Gasser T; Berg D; Maetzler W; Brockmann K
    J Neurol Neurosurg Psychiatry; 2019 Feb; 90(2):165-170. PubMed ID: 30254084
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Integrated Plasma and Neuroimaging Biomarkers Associated with Motor and Cognition Severity in Parkinson's Disease.
    Chen CH; Lee BC; Lin CH
    J Parkinsons Dis; 2020; 10(1):77-88. PubMed ID: 31868681
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer's disease.
    Gangishetti U; Christina Howell J; Perrin RJ; Louneva N; Watts KD; Kollhoff A; Grossman M; Wolk DA; Shaw LM; Morris JC; Trojanowski JQ; Fagan AM; Arnold SE; Hu WT
    Alzheimers Res Ther; 2018 Sep; 10(1):98. PubMed ID: 30253800
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cerebrospinal fluid biomarkers for Parkinson's disease - a systematic review.
    Andersen AD; Binzer M; Stenager E; Gramsbergen JB
    Acta Neurol Scand; 2017 Jan; 135(1):34-56. PubMed ID: 26991855
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Glucosylceramide in cerebrospinal fluid of patients with GBA-associated and idiopathic Parkinson's disease enrolled in PPMI.
    Huh YE; Park H; Chiang MSR; Tuncali I; Liu G; Locascio JJ; Shirvan J; Hutten SJ; Rotunno MS; Viel C; Shihabuddin LS; Wang B; Sardi SP; Scherzer CR
    NPJ Parkinsons Dis; 2021 Nov; 7(1):102. PubMed ID: 34811369
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Associations of blood UCH-L1 and NfL levels with cognitive dysfunction in Parkinson's disease patients.
    Dong L; Chang Q; Ma J; Liu C; Guo D; Li X; Yang D; Fan Y; Liang K; Li D; Gu Q
    Neurosci Lett; 2023 May; 804():137219. PubMed ID: 37023526
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cognitive impairment in Glucocerebrosidase (GBA)-associated PD: Not primarily associated with cerebrospinal fluid Abeta and Tau profiles.
    Lerche S; Schulte C; Srulijes K; Pilotto A; Rattay TW; Hauser AK; Stransky E; Deuschle C; Csoti I; Lachmann I; Zetterberg H; Liepelt-Scarfone I; Gasser T; Maetzler W; Berg D; Brockmann K
    Mov Disord; 2017 Dec; 32(12):1780-1783. PubMed ID: 29094781
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Serum neurofilament is associated with motor function, cognitive decline and subclinical cardiac damage in advanced Parkinson's disease (MARK-PD).
    Niemann L; Lezius S; Maceski A; Leppert D; Englisch C; Schwedhelm E; Zeller T; Gerloff C; Kuhle J; Choe CU
    Parkinsonism Relat Disord; 2021 Sep; 90():44-48. PubMed ID: 34352610
    [TBL] [Abstract][Full Text] [Related]  

  • 76. CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis.
    Olsson B; Lautner R; Andreasson U; Öhrfelt A; Portelius E; Bjerke M; Hölttä M; Rosén C; Olsson C; Strobel G; Wu E; Dakin K; Petzold M; Blennow K; Zetterberg H
    Lancet Neurol; 2016 Jun; 15(7):673-684. PubMed ID: 27068280
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Association of uric acid in serum and urine with subclinical renal damage: Hanzhong Adolescent Hypertension Study.
    Wang Y; Chen C; Yan Y; Yuan Y; Wang KK; Chu C; Hu JW; Ma Q; Liao YY; Fu BW; Gao K; Sun Y; Lv YB; Zhu WJ; Yang L; Zhang J; Yang RH; Yang J; Mu JJ
    PLoS One; 2019; 14(11):e0224680. PubMed ID: 31730636
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cerebrospinal fluid concentrations of inflammatory markers in Parkinson's disease and atypical parkinsonian disorders.
    Hall S; Janelidze S; Surova Y; Widner H; Zetterberg H; Hansson O
    Sci Rep; 2018 Sep; 8(1):13276. PubMed ID: 30185816
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Changes of cerebrospinal fluid Aβ
    Hu X; Yang Y; Gong D
    Neurol Sci; 2017 Nov; 38(11):1953-1961. PubMed ID: 28808876
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The Brain in Kidney Disease (BRINK) Cohort Study: Design and Baseline Cognitive Function.
    Murray AM; Bell EJ; Tupper DE; Davey CS; Pederson SL; Amiot EM; Miley KM; McPherson L; Heubner BM; Gilbertson DT; Foley RN; Drawz PE; Slinin Y; Rossom RC; Lakshminarayan K; Vemuri P; Jack CR; Knopman DS
    Am J Kidney Dis; 2016 Apr; 67(4):593-600. PubMed ID: 26744128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.